Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Surrozen, Inc./DE | 32,412 | reported | 15 Dec 2022 | tx 11+234,219−62,994 |
| Insys Therapeutics, Inc. | 20,935 | reported | 04 Mar 2019 | tx 8+118,036 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Dec 2022 | GRANT_AWARD | Surrozen, Inc./DE | 9,578 | 0.41 USD | |
| 10 Oct 2022 | GRANT_AWARD | Surrozen, Inc./DE | 24,587 | — | deriv |
| 10 Oct 2022 | GRANT_AWARD | Surrozen, Inc./DE | 10,427 | — | deriv |
| 10 Oct 2022 | GRANT_AWARD | Surrozen, Inc./DE | 26,220 | — | deriv |
| 10 Oct 2022 | OTHER | Surrozen, Inc./DE | 1,760 | — | deriv |
| 10 Oct 2022 | OTHER | Surrozen, Inc./DE | 26,220 | — | deriv |
| 10 Oct 2022 | OTHER | Surrozen, Inc./DE | 10,427 | — | deriv |
| 10 Oct 2022 | OTHER | Surrozen, Inc./DE | 24,587 | — | deriv |
| 10 Oct 2022 | GRANT_AWARD | Surrozen, Inc./DE | 1,760 | — | deriv |
| 01 Mar 2022 | GRANT_AWARD | Surrozen, Inc./DE | 125,000 | 3.11 USD | deriv |
| 12 Aug 2021 | GRANT_AWARD | Surrozen, Inc./DE | 36,647 | 0.00 USD | deriv |
| 02 Apr 2018 | GRANT_AWARD | Insys Therapeutics, Inc. | 6,000 | 0.00 USD | |
| 04 Mar 2019 | GRANT_AWARD | Insys Therapeutics, Inc. | 8,083 | 0.00 USD | |
| 02 Apr 2018 | GRANT_AWARD | Insys Therapeutics, Inc. | 24,000 | 0.00 USD | deriv |
| 04 Mar 2019 | GRANT_AWARD | Insys Therapeutics, Inc. | 20,935 | 0.00 USD | deriv |
| 02 Apr 2018 | GRANT_AWARD | Insys Therapeutics, Inc. | 6,000 | 0.00 USD | |
| 04 Mar 2019 | GRANT_AWARD | Insys Therapeutics, Inc. | 8,083 | 0.00 USD | |
| 02 Apr 2018 | GRANT_AWARD | Insys Therapeutics, Inc. | 24,000 | 0.00 USD | deriv |
| 04 Mar 2019 | GRANT_AWARD | Insys Therapeutics, Inc. | 20,935 | 0.00 USD | deriv |